A shorter MPFI designed specifically for patients with chronic pain proved generally valid and reliable on a group level, according to a recent study.

While a wearable technology that assists the lower back muscles has great potential to cut down on workplace injuries, it ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer ...

Atreon Orthopedics earned FDA 510(k) clearance for the BioCharge autobiologic matrix and launched the new product, according to a Feb. 20 news release.

"Sinus passages can become inflamed from an infection or allergies leading to the trapping air, fluid, and mucus inside — this creates pressure that leads to pain in the forehead, cheeks ...

It works by switching off nociceptors in the peripheral nervous system, and therefore preventing pain signals getting to the ...

The FDA approved a new type of pain reliever that doesn’t include opioids. CNN’s Chief Medical Correspondent Dr. Sanjay Gupta answers your questions about the side effects and the unusual history ...

Pain under the left armpit may result from muscle damage or swollen lymph nodes due to an infection. However, it can also indicate a more serious problem, such as cancer or angina. The armpit is a ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

If you live with pain, you probably know that spending a set amount of time in bed doesn’t automatically translate to good sleep. You likely don’t feel very rested if you spend most nights ...

Common reasons for back pain include muscle strain, disk damage, and some chronic conditions, such as fractures due to osteoporosis. Potential treatments include heat therapy, acupuncture ...